Skip to content
Search

Latest Stories

World's first AI diabetes risk tool to be tested by NHS in 2025

AI-diabetes-risk-tool-iStock

THE NHS in England is set to launch a world-first trial of an artificial intelligence (AI) tool that predicts the risk of developing type 2 diabetes up to 13 years before symptoms appear.

The trial, scheduled for 2025, will take place at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust, The Guardian reported.


The AI technology, known as Aire-DM, analyses electrocardiogram (ECG) readings during routine heart scans to detect subtle changes in the heart's electrical activity. These changes, which are too small to be noticed by the human eye, could indicate a future risk of type 2 diabetes.

Type 2 diabetes, which affects over 500 million people globally, is a leading cause of blindness, kidney failure, heart attacks, strokes, and amputations.

Experts estimate that the number of cases worldwide could reach 1 billion by 2050, the newspaper reported. The new AI tool offers the potential for early interventions, such as dietary and lifestyle changes, to prevent or delay the onset of the disease.

The technology was developed by a team led by Dr Fu Siong Ng and Dr Arunashis Sau at Imperial College London.

They used 1.2 million ECG records and validated the tool using data from the UK Biobank, which contains medical and genetic records of over 500,000 participants. Aire-DM identifies patterns in ECGs that are more common among those likely to develop diabetes in the future.

The tool has shown a predictive accuracy of about 70 per cent across diverse demographics, with accuracy improving further when combined with clinical and genetic data, The Guardian reported.

Dr Libor Pastika, a clinical research training fellow at Imperial, described the technology as a “revolutionary” way to predict type 2 diabetes risk early and enable preventive care.

Professor Bryan Williams, the British Heart Foundation's chief scientific and medical officer, added that this development could be a “gamechanger” in tackling a rapidly growing health challenge.

More For You

Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less
Eric Dane

There is currently no cure for ALS

Getty

Grey’s Anatomy and Euphoria star Eric Dane diagnosed with ALS

Eric Dane, best known for his roles in Grey’s Anatomy and Euphoria, has revealed he has been diagnosed with amyotrophic lateral sclerosis (ALS).

ALS, also referred to as motor neurone disease (MND) in the UK, is an incurable condition that progressively damages nerve cells in the brain and spinal cord, leading to increasing muscle paralysis. The disease affects around 153,000 people in the UK, though awareness of its wider range of symptoms remains relatively low.

Keep ReadingShow less
Top 10 Early Warning Signs of Parkinson’s Disease You Need to Know

Parkinson’s can impact quality of life

iStock

10 early warning signs of Parkinson’s disease you should know

Parkinson’s disease is the world’s fastest-growing neurological condition, yet public understanding often stops at its well-known tremors.

Despite affecting 153,000 people in the UK, awareness around its wider range of symptoms remains limited, according to Parkinson’s UK. Even with famous figures like Billy Connolly, Michael J. Fox, Neil Diamond, Linda Ronstadt, and Ozzy Osbourne speaking openly about living with the disease, many early signs still go unrecognised.

Keep ReadingShow less
8 packaged foods recalled in UK in the last month

These food recalls show how important it is to check labels and stay updated on safety alerts

iStock

8 packaged foods recalled in UK in the last month

Food recalls in the UK are issued when products pose risks to consumers. These risks can range from contamination to allergen mislabelling, and staying informed about these recalls is crucial for consumer safety. Recent recalls emphasize the importance of vigilance when purchasing and consuming food items. If you’ve recently stocked up on groceries, it’s time to check your pantry and fridge to ensure none of the items listed below are affected.

1. Tony’s Chocolonely Chocolate Bars

On April 2, 2025, Tony’s Chocolonely recalled its Dark Almond Sea Salt & Everything Bar after discovering small stones in the product. The presence of foreign objects in food can pose serious risks, such as dental damage or choking hazards. The company has urged customers to return the affected items immediately to avoid potential harm. If you have recently purchased this product, check your packaging and return it to the store where it was bought for a full refund.

Keep ReadingShow less
Coeliac Disease: What to Know After Rebecca Adlington’s Diagnosis

Olympic swimmer Rebecca Adlington has recently revealed about her condition

Getty Images

Key things to know about Coeliac disease after Rebecca Adlington’s diagnosis

Olympic swimmer Rebecca Adlington has recently revealed her diagnosis of coeliac disease and has called for greater awareness of the condition. In a video shared on Coeliac UK’s Instagram, Adlington discussed the importance of gluten-free prescriptions and urged the government to protect access to these prescriptions, which have been cut in some areas.

Her diagnosis shines a light on coeliac disease, a condition that affects approximately 1 in 100 people in the UK. However, due to the difficulty in recognising the symptoms, only around 36% of people living with the condition have been officially diagnosed.

Keep ReadingShow less